A method of extracting disease-related microRNAs through the propagation algorithm using the environmental factor based global miRNA network.
暂无分享,去创建一个
Youngmi Yoon | Jihwan Ha | Sanghyun Park | Sanghyun Park | Youngmi Yoon | Jihwan Ha | Hyunjin Kim | Hyunjin Kim
[1] M. de Zwaan,et al. Influence of stress and health-behaviour on miRNA expression. , 2010, Molecular medicine reports.
[2] 王姮,et al. Obesity genes , 2003 .
[3] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[4] John P. Overington,et al. How many drug targets are there? , 2006, Nature Reviews Drug Discovery.
[5] Yadong Wang,et al. miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..
[6] Changning Liu,et al. dbDEMC: a database of differentially expressed miRNAs in human cancers , 2010, BMC Genomics.
[7] Q. Cui,et al. Prediction of Disease-Related Interactions between MicroRNAs and Environmental Factors Based on a Semi-Supervised Classifier , 2012, PloS one.
[8] J. Gies,et al. Drugs and their molecular targets: an updated overview , 2008, Fundamental & clinical pharmacology.
[9] Dong Wang,et al. Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..
[10] Xing Chen,et al. RWRMDA: predicting novel human microRNA-disease associations. , 2012, Molecular bioSystems.
[11] Laura Pelletier,et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations , 2008, Hepatology.
[12] Yadong Wang,et al. Prioritization of disease microRNAs through a human phenome-microRNAome network , 2010, BMC Systems Biology.
[13] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[14] Qing Wu,et al. miREnvironment Database: providing a bridge for microRNAs, environmental factors and phenotypes , 2011, Bioinform..
[15] C. Sonnenschein,et al. Environmental causes of cancer: endocrine disruptors as carcinogens , 2010, Nature Reviews Endocrinology.
[16] J. Drews. Drug discovery: a historical perspective. , 2000, Science.
[17] Jan Gorodkin,et al. Protein-driven inference of miRNA–disease associations , 2013, Bioinform..
[18] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[19] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[20] P. Beales,et al. Obesity genes , 1996, Clinical endocrinology.
[21] Hailin Chen,et al. Similarity-based methods for potential human microRNA-disease association prediction , 2013, BMC Medical Genomics.
[22] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[23] Wong-Ho Chow,et al. Epidemiology and risk factors for kidney cancer , 2010, Nature Reviews Urology.
[24] Zhen Lin,et al. miRNAs in the pathogenesis of oncogenic human viruses. , 2011, Cancer letters.
[25] Yang Li,et al. HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..
[26] Ulrich Pfeffer,et al. Modulation of microRNA expression by budesonide, phenethyl isothiocyanate and cigarette smoke in mouse liver and lung. , 2010, Carcinogenesis.
[27] U. Das,et al. Obesity: genes, brain, gut, and environment. , 2010, Nutrition.
[28] Yun Xiao,et al. Prioritizing candidate disease miRNAs by integrating phenotype associations of multiple diseases with matched miRNA and mRNA expression profiles. , 2014, Molecular bioSystems.
[29] Dean A Fennell,et al. MicroRNA regulation of core apoptosis pathways in cancer. , 2011, European journal of cancer.
[30] Claus Belka,et al. MicroRNA expression profiles in human cancer cells after ionizing radiation , 2011, Radiation oncology.